Atypical E2Fs inhibit tumor angiogenesis

Autor: Bart Westendorp, Stefan Schulte-Merker, M Zijp, W J Bakker, B T Hien, Bart Weijts, Rachel E. Thomas, L M Martínez-López, A. de Bruin, Ingrid Thurlings

Publikováno v: Oncogene, 37, 271. Nature Publishing Group
ONCOGENE, 37(2), 271-276. Nature Publishing Group
Oncogene, 37(2), 271-276. Nature Publishing Group
Oncogene, 37(2), 271. Nature Publishing Group
Oncogene

Atypical E2F transcription factors (E2F7 and E2F8) function as key regulators of cell cycle progression and their inactivation leads to spontaneous cancer formation in mice. However, the mechanism of the tumor suppressor functions of E2F7/8 remain ob

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::365844f8d9941687f94eb1d86431a330
https://dspace.library.uu.nl/handle/1874/388249